Pfizer
Developer of prescription medicines and vaccines across oncology, internal medicine, immunology and infectious disease.
$27.95
After-hours close−0.01 (−0.04%)
At close$27.96(−0.21%)
Something off on this page? Send us feedback.
Breakdown13F · Form 4
Institutions 71.54%4.08B sharesInsiders 0.02%1.40M sharesOther 28.44%1.62B shares
Shares outstanding 5.70B · Float 5.69B · 99.9% free float
Institutions13F, as of Jun 30, 2026
2,939 holders · 4.08B shares · 149 new positions · 1,301 increased · 1,228 reduced · 285 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| BlackRock, Inc. | 529.67M | 9.29% | +31.41M | Aug 7, 2026 |
| Vanguard Capital Management LLC | 372.15M | 6.53% | +2.72M | Aug 13, 2026 |
| State Street Corp | 307.09M | 5.39% | +5.50M | Aug 7, 2026 |
| Geode Capital Management, LLC | 135.28M | 2.37% | +1.71M | Aug 12, 2026 |
| Vanguard Portfolio Management LLC | 119.24M | 2.09% | +2.50M | Aug 13, 2026 |
| Fisher Asset Management, LLC | 109.07M | 1.91% | +4.10M | Aug 4, 2026 |
| Morgan Stanley | 96.35M | 1.69% | +3.66M | Aug 13, 2026 |
| Norges Bank | 61.51M | 1.08% | +61.51Mnew | Aug 12, 2026 |
Beneficial owners13D/G · 5% or more, as filed
No 13D/G filer at 5% or more on record.
InsidersForm 4
| Insider | Role | Shares | % outstanding | Filed |
|---|---|---|---|---|
| Albert Bourla | director, officer: Chairman & CEO | 429.2K | 0.01% | Aug 12, 2026 |
| Sally Susman | officer: Executive Vice President | 168.9K | 0.00% | Mar 3, 2025 |
| Douglas M. Lankler | officer: Executive Vice President | 163.2K | 0.00% | Feb 27, 2026 |
| Christoffel Boshoff | officer: President, R&D | 161.4K | 0.00% | Feb 27, 2026 |
| Cecile Guegan | officer: Executive Vice President | 149.5K | 0.00% | Aug 28, 2026 |
| Michael McDermott | officer: Executive Vice President | 74.3K | 0.00% | Feb 27, 2026 |
| Ronald E. Blaylock | director | 66.9K | 0.00% | Aug 5, 2026 |
| Dennis P. Hancock | officer: Executive Vice President | 47.0K | 0.00% | Apr 27, 2026 |
| Lidia Fonseca | officer: Executive Vice President | 46.5K | 0.00% | Feb 27, 2026 |
| Mortimer J. Buckley | director | 37.6K | 0.00% | Aug 5, 2026 |
51 people have not refiled in the last 18 months (11.97M shares), so they are not in the figure above
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Aug 12, 2026 | Albert Bourladirector, officer: Chairman & CEO | Purchase | 38,000 | $26.34 | 429,173 |
| Aug 5, 2026 | Jennifer B. Damicoofficer: SVP & Controller | Sale | 3,278 | $25.40 | 28,611 |
| Aug 5, 2026 | Mortimer J. Buckleydirector | Purchase | 37,632 | $25.52 | 37,632 |
| Aug 5, 2026 | Ronald E. Blaylockdirector | Purchase | 39,231 | $25.46 | 66,938 |
| Jun 9, 2026 | Jennifer B. Damicoofficer: SVP & Controller | Sale | 2,000 | $25.70 | 31,397 |
CongressHouse and Senate disclosures
| Member | Type | Amount | Owner | Traded | Disclosed |
|---|---|---|---|---|---|
| Rep. Carol Devine Miller · WV01 | Sale | $15,001 – $50,000 | Spouse | Mar 10, 2025 | Aug 14, 2026 ↗ |
| Rep. Ro Khanna · CA17 | Purchase | $1,001 – $15,000 | Jul 7, 2026 | Aug 12, 2026 ↗ | |
| Rep. Michael Rulli | Sale | $1,001 – $15,000 | Nov 26, 2024 | Aug 10, 2026 ↗ | |
| Sen. Tommy Tuberville · AL | Sale | $15,001 – $50,000 | Joint | Jun 8, 2026 | Jul 16, 2026 ↗ |
| Rep. Ro Khanna · CA17 | Purchase | $1,001 – $15,000 | Spouse | Apr 13, 2026 | May 13, 2026 ↗ |